1. Gans, H.: Introduction to Hepatic Surgery. 1955 Elsevier  Publishing Company, Amsterdam, Houston, London, New York.
2. Gans, H.: Study of Anatomy of the Intrahepatic Structures and its Repercussions of Hepatic Surgery. Doctorial Thesis. July 1955 University of Nijmegen, Holland, Elsevier Publishing Company, Amsterdam.
3. Gans, H.: De Lever als een Gepaard, Gelobd en Gesegmenteerd Orgaan. Ned.Tydschr.v.Geneesk. 99:3394, 1955.
4. Gans, H.: The Intrahepatic Anatomy and its Repercussions on Surgery. (Preliminary Report) Arch.Chirurg.Neerland 7:131, 1955​.
5. Gans, H. and Bax, H.R.: Partial Resection of the Liver in Early Carcinoma of the Gallbladder (Middle Lobectomy). Process Verbeaux du XVI Congres de la Soc. Int. Chir., Copenhague. 24-31, p. 1147-60, July 1955.
6. Gans, H.: Over de Hemihepatectomie. Ned.Tydschr.v.Geneesk. 99:1693, 1955.
7. Gans, H. and Krivit, W.: Effect of Endotoxin Shock on the clotting Mechanism of Dogs. Ann. Surg. 152:69, 1960.
8. Gans, H. and Krivit, W.: Effect of Endotoxin on the Clotting Mechanism. II. On the Variation in Response in Different Species of Animals. Ann. Surg. 153:453, 1961.
9. Gans, H. and Krivit, W.: Effect of Endotoxin Studies of Fibrinogen and Plasminogen Concentrations in Rabbits during Anaphylactic Shock. J. Lab. Clin. Med. 58:259, 1961.
10. Gans, H. and Krivit, W.: Hemostatic Defects in Patients Undergoing Cardiac Bypass. Surg. Forum 12:202,1961.
11. Gans, H.: Thrombosis and Thrombolysis. A Review. Surg. Gyn. Obst. 113:513, 1961.
12. Gans, H. and Krivit, W.: Problems in Hemostasis during Open-Heart Surgery. I. On the Release of Plasminogen Activator. Ann. Surg. 154:915, 1961.
13. Gans, H. and Krivit, W.: Problems in Hemostasis during Open-Heart Surgery.  II. On the Hypercoagulability of Blood during Cardiac Bypass. Ann. Surg. 156:19, 1962.
14. Gans, H. and Krivit, W.: Problems in Hemostasis during Open-Heart Surgery.  III. Epsilon Amino Caproic Acid as an Inhibitor of Plasminogen Activator Activity. Ann. Surg. 155:258, 1962.
15. Gans, H. and Krivit, W.: Problems in Hemostasis during Open-Heart Surgery. IV. On the Changes in the Blood Clotting Mechanism during Cardiopulmonary Bypass Procedures. Ann. Surg. 155:353, 1962.
16. Gans, H. and Krivit, W.: Idem. VI. Overall Changes in Blood Coagulation Mechanism. J.A.M.A. 179:145, 1962.
17. Redleaf, P., Davis, R.B., Kucinski, C., Hoiland, L. and Gans, H.: Amyloidosis with Unusual Bleeding Diatheses. Observations on the Use of Epsilon Amino Caproic Acid. Ann. Int. Med. 58:347, 1963.
18. Gans, H.: On the Discovery of the Lymphatic Circulation. Angiology 13:530, 1962.
19. Gans, H.: Chemopathology of the Shwartzman Phenomenon. J. Ang. 14:40, 1963.
20. Gans, H.: Changing Concepts in Thrombosis and Thrombolysis. Surg. 53:531, 1963.
21. Gans, H., Hanson, M. and Krivit, W.: Effect of Endotoxin on the clotting Mechanism. III. On the Relationship between Hypercoagulability, Plasminogen Activator Activity and Antithrombin Activity. Surg. 53:792, 1963.
22. Lillehei, C.W. and Gans, H.: Management of Hemostasis during Open-Heart Surgery. In Conference on Bleeding in the Surgical Patient. New York Acad. Sci. 115, July 1964.
23. Gans, H.: The Study of Fibrinogen Turnover Rates after Total Hepatectomy in Dogs. Surg. 55:544, 1964.
24. Gans, H.: Study of the Fibrinolytic and Anticoagulant Mechanisms following Thrombin Infusions in Normal and Reversed Eck Fistula Dogs.  Ph.D. Thesis University of Minnesota, May, 1964.
25. Gans, H.: The Use of E.A.C.A. (Editorial) Surg. Gyn. Obst. 120:576, 1965.
26. Gans, H.: Study of the Fibrinolytic and Anticoagulant Activity during a Thrombin-Induced Hypercoagulability State in Dogs. J. Exp. Surg. 6:87, 1966.
27. Gans, H., Koh, S. and Aust, J.B.: Hepatic Resections. Results in 39 patients operated upon during a 10-year period. 1953-63 at University of Minnesota Hospitals. Arch. Surg. 93:523, 1966.
28. Gans, H.: The Thrombogenic Properties of E.A.C.A. Ann. Surg. 163:175, 1966.
29. Bernstein, E and Gans, H.: Anticoagulant Activity of Angiographic Contrast Media. Inv. Rad. 1:162, 1966.
30. Gans, H., Lowman, J. and Fahr, G.: Uptake of Intact and Disintegrated Platelets by the Isolated Perfused Rat Liver. (Abstract) Fed. Proc. 25:2900, 1966.
31. Gans, H., Lowman, J. and Tan, B.H. (Sponsored by G. Fahr):  Uptake of Rat Fibrin and Rat F.D.P. by Isolated  Perfused Rat Liver. (Pharmacology) (Abstract) Fed. Proc. 25:46, 1966.
32. Gans, H.: Study of Mechanisms which Preserve Blood Fluidity and the Effect of their Inhibition on Thrombogenesis. J. Surg. Res. 6:87, 1966.
33. Gans, H.: Preservation of Vascular Patency as a Function of Reticuloendothelial Clearance. Surg. 60:1216, 1966.
34. Gans, H. and Lowman, J.: The Uptake of Fibrin and Fibrin Degradation Products by the Isolated Perfused Rat Liver Blood 29:526, 1967.
35. Gans, H., McLeod, J. and Lowman, J.T.: A New Technique for the Production of an in Vivo Labeled Fibrinogen. Blood           29:517, 1967.
36. Gans, H., Castaneda, A.R., Lillehei, C.W., Subramanian, V. and John, S.: Problems in Hemostasis during Open-Heart Surgery. VII. On the Changes in Fibrinogen Concentration during and after Cardiopulmonary Bypass with Particular Reference to the Effect of Heparin Neutralization on Fibrinogen. Ann. Surg. 165:551, 1967.
37. Gans, H., Castaneda, A.R., Lillehei, C.W., Subramanian, V. and John, S.:  Problems in Hemostasis during Open-Heart Surgery. VIII. On the in Vivo Turnover Rate of Plasminogen Activator. Surg. 62:292, 1967.
38. Gans, H. et al: Problems in Hemostasis during Open-Heart Surgery. IX. Changes Observed in the Plasminogen-Plasmin System and their Significance for Therapy. Ann. Surg. 166:980, 1967.
39. Gans, H., Lowman, J.T., Subramanian, V. and Tan, B.H.:  Preservation of Vascular Patency as Function of Reticuloendothelial Clearance. II. Selectivity of  Phagocytosis for Different Protein Molecules Derived from Two Clotting Proteins of Plasma. Surg. 62:698, 1967.
40. Gans, H. and Tans, B.H.: Alpha-antitrypsin, An Inhibitior for Thrombin and Plasmin. Clin. Chim. Acta 17:111, 1967.
41. Castaneda, A. , Gans, H., Weber, K.C. and Fox, I.J. Heparin Neutralization: Experimental and Clinical Studies. Surg. 62:686, 1967.
42. Carlson, et al: Myocardial Revascularization: Role of Myocardial Tunnel Length as a Determinant of Implant Patency. Circ. 36 (Suppl. II): 81, 1967.
43. Gans, H., Subramanian, V., John, S., Castaneda, A. and Lillehei, C.W.: Theoretical and Practical (Clinical) Considerations concerning Proteolytic Enzymes and their Inhibitors with Particular Reference to Changes in the Plasminogen-Plasmin System Observed during Assisted Circulation in Man. Ann. N.Y. Acad. Sci. 146:721, 1968.
44. Gans, H., Subramanian, V. and Tan, B.H.: Selective Phagocytosis: A New Concept in Protein Chemistry. Science 159:107, 1968.
45. Gans, H., Subramanian, V. and Tan, B.H.:  Studies on the Turnover of Thrombin. (Abstract) Thromb. Diath. Haem. 19:604, 1968.
46. Gans, H.: Diagnosis and Management of Hemorrhagic Diseases. G.P. 37:130, 1968.
47. Gans, H. and Stern, R.: Study of the Endocytosis of Proteins. J.  Ret. End. Soc. 5, No. 6, p. 10, 1968 (Abstract).
48. Carlson, R.G., Edlich, R.F., Subramanian, V., Lande, A., Gans, H. and Lillehei, C.W.: Role of antithrombogenic mechanisms as a determinate of implant patency in myocardial revascularization. Proc. Int. Union of Physiol. Sci. 7:74, 1968 (Abstract).
49. Carlson, R.G., Edlich, R.F., Subramanian, V.A., Lande, A.J., Bonnabeau, R.C., Gans, H. and Lillehei, C.W.: Myocardial Revascularization.  II. Role of Antithrombogenic Mechanisms as a Determinant of Implant Patency. Angio. 20:107, 1969.
50. Carlson, R.G., Edlich, R.F., Lande, A.J., Bonnabeau, R.C. Gans, H. and Lillehei, C.W.: A New Concept for the Rationale of the Vineberg Operation for Myocardial Revascularization. Surg. 65:141, 1969.
51. Gans, H., Edson, J.R., Tan, B.H., Ebert, R.V. and Boulton, A.: Recurrent Thromboembolism: Report of a Case and Inquiry into the Nature of the Fast Antiplasmin. Surg. Vol. 66, No. 6, pp. 1014-1021, 1969.
52.  Gans, H., Stern, R. and Tan, B.H.: On the in Vivo Clearance of Thrombin. Thromb. Diath. Haem. 22:1, 1969.
53. Gans, H. and Boulton, A.: Differences in the Effect of Antithrombin on Thrombin Clotting and Thrombin Esterase Activity. Thromb. Diath. Haem. 22:28, 1969.
54. Gans, H., Sharp, H. and Tan, B.H.: Antiprotease Deficiency and Familial Infantile Liver Cirrhosis. Surg. Gyn. Obst. Vol. 129, 289-299, 1969bibliography_54.pdf.
55. Gans, H., Stern, R. and Tan, B.H.: Effect of Hepatectomy on Thrombin Clearance. Ann. Surg. Vol. 170, No. 6, p. 937, 1969.
56. Gans, H.: Bleeding Problems in the Sugical Patient. Curr.  Prob. Surg. July, 1969.
57. Tan, B.H. and Gans, H.: Alpha1-antitrypsin. III. Isolation and Purification from Bovine Plasma. Pharmaceutisch. Weekblad. (Special Issue: Dr. E.H. Vogelenzang) 26:717, 1969.
58. Gans, H., Rosenberg, M., Tan, B.H. and Boulton, A.: Study of the Mechanism of Spontaneous Resolution of Thromboemboli. Surg. Gyn. Obst. Vol. 130, 326-332, 1970.
59. Mori, K., Quinlan, R., Richter, D., Kaster, R., Tan, B.H. and Gans, H.: Characterization of the acute hepatic failure syndrome associated with the anhepatic state. Surg. Gyn. Obst. 131:919, 1970.
60. Gans, H.: Abnormal bleeding during surgery. Arch. Chir. Neerlandicum. Vol. 23:75, 1971.
61. Tan, B.H., Mori, K., Richter, D., Quinlan, R. and Gans, H.: Study of the defibrination syndrome associated with acute hepatic failure. Surg. Gyn. Obst. 132:263, 1971.
62. Gans, H., Mori, K., Lindsey, E., Kaster, B., Richter, D., Quinlan, R., Dineen, P.A. and Tan, B.H.: Septicemia as a Manifestation of Acute Hepatic Failure. Surg. Gynecol. Obstet. 132:783, 1971.
63. Gans, H., Mori, K., Quinlan, R., Richter, D. and Tan, B.H.: The Intestine as a Source of Plasminogen Activator Activity. Proc. Soc. Exp. Biol. Med. 136:627, 1971.
64. Gans, H.: Discussion of Mays, T.E.: Hepatic Lobectomy. Arch. Surg. 103:227, 1971.
65. Tan, B.H. and Gans, H.: The Isolation and Purification of Bovine Alpha1-Antitrypsin. Pulmonary Emphysema and Proteolysis, C. Mittman Ed., Acad. Press, New York, London, p361-377, 1972.
66. Mori, K., Tan, B.H. and Gans, H.: In Vivo Turnover of Bovine Alpha1-Antitrypsin. Pulmonary Emphysema and Proteolysis, C. Mittman Ed.,  Acad. Press, New York, London, p379-386, 1972.
67. Gans, H.: Considerations on the Etiology of the Hepatic Injury Observed in Patients with Homozygous Alpha1-Antitrypsin Deficiency. Pulmonary Emphysema and Proteolysis, Mittman Ed., Acad. Press, New York, London, p115-119, 1972.
68. Tan, B.H., McCoy, L. and Gans, H.: Study of Mechanism of  Selective Phagocytosis. (Abstract) J. Ret. Endoth. Soc. 11:418, 1972.
69. Mori, K., and Gans, H.: The in vivo clearance and detoxification of endotoxin by the Liver. (Abstract) J. Ret. Endoth. Soc. 11:438, 1972.
70. Gans, H.: An early example of the use of surgical techniques in solving a physiologic problem. Surg. Gynecol. Obstet. 135:616, 1972.
71. Gans, H., Matsumoto, K., Mori, K.: Antibodies and Intravascular Clotting in Liver Cirrhosis. The Lancet, No. 7761, Pg. 1181, May, 1972.
72. Mori, K. Matsumoto, K. and Gans, H.: On the in vivo clearance and detoxification of endotoxin by lung and liver. Annals of Surgery, Vol. 177:159, 1973.
73. Gans, H.: Is Primary Fibrinolysis a Real Entity? (Editorial) Surg. Gynecol. Obstet. 136:975, 1973.Gans, H.: Enzyme Transplants. Letter to Editor, The Lancet, No. 7796, Pg. 203, January, 1973.
74. Gans, H., Stern, R. and Tan, B.H.: Effect of Hepatectomy on Thrombin Clearance in Pinocytosis, Addresses, essays, lectures. Frank S. Rabella Editor, M.S.S. Information Corp., New York, 1974.
75. Gans, H., Mori, K. and Tan, B.H.: Evaluation of the Effects of the Finger Fracture Technique Used in Heptic Resection. Surg. Gynecol. Obstet. 138:885, 1974.
76. Gans, H. and Matsumoto, K.: On the Escape of Endotoxin from the Intestine. Endosymposium, Karger Verlag, 1974.
77. Gans, H.: Endotoxemia in Liver Disease. The Lancet, 1:931, 1974.
78. Gans, H.: Phagocytosis. Letter to Editor, Surgery 76:352, 1974.
79. Gans, H. and Matsumoto, K.: On the Escape of Endotoxin from the Intestine. Surg. Gynecol. Obstet. 139:395, 1974.
80. Gans, H. and Matsumoto, K.: Are Enteric Endotoxin Able to Escape from the Intestine? Proc. Soc. Exp. Biol. Med. 147:736, 1974.
81. Gans, H.: Effect of ligation of the hepatic artery or occlusion of the portal vein on the development of endotoxemia. Surg. Gynecol. Obstet. 139:689, 1974.
82. Gans, H.: Effect of prolonged extracorporeal circulation on macrophage function. Extracorporeal Membrane Oxygenator Workshop Verbatim Transcript Sept. 27-28th Meetings, Stouffer’s National Center Inn, Arlington, Virginia. ECMO Contract #NO1-HO-4-2936 N.I.H., 1974.
83. Gans, H.: Tradition and Innovation: Reflections on Selected Historical Highlights in the Field of Hepatic Surgery. Surgery 77:593-601, 1975.
84. Gans, H.: Mechanism of Heparin Protection in Endotoxin Shock. Surgery 77:602-606, 1975.
85. Gans, H.: Fibrin deposition as a dynamic rather than a static process. Letter to Editor, Archives of Surgery 111:614, 1976.
86. Gans, H., and Wendell, G.: Evaluation of the possible role of serum factors in the clearance of endotoxin from blood. J Surg Res 21:415, 1976 (Dec).
87. Gans,  H: Hazards of Heparin Therapy, Archives of Surgery 11:614, 1976.
88. Gans, H.: Letter to Editor (on xenografted transplanted cells). Surgery 81:731, 1977.
89. Gans, H.: Abnormal Bleeding During and After Surgery.  Chapter XIII in Complications of Thoracic Surgery, Ellison and Cordell.  In press.
90. Gans, H.: Effect of Kupffer cell deficiency in the rat: I. The development of systemic endotoxemia and its effect on the liver. J Reticuloendoth Soc 24 Suppl 25a, 1978. (Abstract)
91. Gans, H., and Kugler, D.: Effect of Kupffer cell bypasss on serum proteins. J Reticuloendoth Soc 24 Suppl 30a, 1978. (Abstract)
92. Wolf, C.F.W., Gans, H., Subramanian, V.A., and McCoy, C.H.: A rat model for study of bilirubin conjugation by cultured cell. Artificial capillary liver assist device. Int J Artif Organs 2:97-103, 1979.
93. Gans, H.: Practical and theoretical considerations concerning Kupffer cell function in protein catabolism. International Biomedical Symposium on The Reticuloendothelial System (RES) and the Pathogenesis of Liver Disease, Wurzburg, West Germany, September 29 - October 1, 1979. 
94. Wisse, Liehr, and Popper (Eds.), Elsevier Publishing Company, Amsterdam, New York, p.79-89, 1980.
95. Babb, J.L., Billing, P.A., Yamaguchi, Y., and Gans, H.: Endotoxins and hepatorenal syndrome (letter). Lancet 2:925, 1980.
96. Babb, J.L., Billing, P.A., Gans, H., and Yamaguchi, Y.: Immunoregulation by hepatotoxins. Fed Am Soc Exp Biol, Atlanta, Georgia, April 12-17, 1981.  (Abstract)
97. Gans, H., Prabhudesai, M., Babb, J., Billing, P., and Yamaguchi, Y.: Mechanism of CC14 induced hepatotoxicity. Gastroenterology,  Vol. 80, No. 5, Part 2, May 1981, p. 1333. (Abstract)
98. Yamaguchi, Y., Babb, J., Billing, P., and Gans, H.: Invivo assessment of endotoxin inactivation by the rat liver. Gastroenterology, Vol. 80, No. 5, Part 2, May 1981, p. 1334. (Abstract)
99. Duy, N., Yamaguchi, Y., Prabhudesai, M., Babb, J., and Gans, H.: Cancer of the bladder in the portacaval shunted rat. Gastroenterology, Vol. 80, No. 5, Part 2, May 1981, p. 1331. (Abstract)
100. Gans, H.: Letter to the Editor, Hepatology, 2:292, 1982.
101. Yamaguchi, Y., Babb, J.L. and Gans, H.: In vivo quantization of the rat liver’s ability to eliminate endotoxin from portal vein blood. J. Reticloendothel. Soc. 32:409, 1982.
102. Babb, J.L., Billing, P.A., Gans, H., and Yamaguchi, Y.: Acute hepatotoxin exposure effects lymphocytes and accessory cell types in inbred mice. Proc. Soc. Exp. Med. Biol. 174:392, 1983.
103. Yamaguchi, Y., Duy, N., Prahudesai, M., Babb, J.L. and Gans, H.: Morphologic changes in the uroepithelium following portacaval  shunting in the rat. Gastroenterology: 86:1347, 1984.
104. Gans, H.: R.E.S1 Control of Endotoxemia. Chapter 8, Vol. VIIa - Physiology of the Reticuloendothelial System, Eds. J.P. Filkins and S.M. Reichard; The Reticuloendothial System: A Comprehensive Treatise. Plenum Publishing Corp. , New York. P115-143, 1984.
105. Yamaguchi, Y., Yamaguchi, K., Billing, P.A. Babb, J.L.  Mori, K., Akagi., M. and Gans, H.: Endotoxin inactivation of rat serum. Proc. Soc. Exp. Med. Biol. 181:163, 1986.
106. Yamaguchi K, Gans H, Yamaguchi Y, Hagisawa S: External Compression with elastic Bandages: its Effect on the Peripheral Circulation during Skin Traction. Arch Phys Med Rehab 67:326, 1986.
107. Yamaguchi Y, Mori K, Gans H, Akagi M: Enhanced Endotoxin Clearance in Reversed Eck Fistula Rats during a Tolerant Stage, Japan J Surg 16:209, 1986.
108. Yamaguchi Y, Mori K, Gans H, Akagi M: Endotoxin Inactivation by the Humoral Components in the tolerant rat serum, Toxicolgy 45:257, 1987.
109. Gans, H: DIC after Hepatic Resection, Surgery 109:804, 1991.
110. Gans, H: Split-Liver Transplantation, Surgery 120:120, 1996.
111. Mary Ann and Henry Gans: Lowball Appraisals, Maine Antique Digest 3A, 1999.
112. Gans, H: On the Lung Injury and DIC seen after Liver Trauma. Surgery 127:477, 2000.
113. Gans, H: Pharmaceutical Control of Bleeding during Cardiac Surgery, Lancet, 355:753, 2000.
114. Gans, H: Circumstance and Serendipity. Surgery 130:130, 2001.
115. Gans, H: The Idea and the Experiment, Lancet, 357:148, 2001.
116. Gans,  H: A Word of Advice, Lancet 357:695, 2002.
117. Gans, H Serge Nekrassoff: The Metal Worker as Nature Painter, Maine Antique Digest, 14C, May 2002.
118. Gans, H: Development of Modern Liver Surgery, Lancet 360:805, 2002.bibliography_118.pdf
119. Gans, H: A Thank You to a Dutch Famer, Lancet 364:2095, 2004.
120. Gans, H: Fifty Years Ago, Surgery 148:162, 2010.